Abstract
Purpose Uveal melanoma undergoes haematogenous dissemination, particularly to the liver. It is routine practice to screen for metastatic disease. The purpose of this study was to evaluate such screening tests and to determine their value in detecting metastatic disease at presentation.
Methods In this study of a series of 245 patients with uveal melanoma of whom 55 (22%) died, the sensitivity, specificity, positive and negative predictive powers and likelihood ratio of the blood tests, chest radiographs and liver ultrasound investigations performed at diagnosis were determined.
Results All the screening investigations were found to have a low yield, but the most sensitive were those for gamma-glutamyl transpeptidase (γGT;sensitivity 21%) and alkaline phosphatase (sensitivity 25%), with 7GT being more specific (specificity 92%). No blood test had a positive predictive power greater than 50%. The chest radiograph and liver ultrasonography were both 100% specific but had sensitivities of 2% and 14% respectively.
Conclusions Only the chest radiograph and liver ultrasonography had positive predictive powers greater than 50% and these tests had very poor sensitivity. We conclude that there is no good test available for screening for metastatic uveal melanoma.
Similar content being viewed by others
Article PDF
References
McLean IWD, Foster WD, Zimmerman LE . Prognostic factors in small malignant melanomas of choroid and ciliary body. Arch Ophthalmol 1977;95:48–58.
Shammas HF, Blodi FC . Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol 1977;95:63–9.
McLean IW, Foster WD, Zimmerman LE . Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis. Hum Pathol 1982;13:123–32.
Rajpal S, Moore R, Karakousis CP . Survival in metastatic ocular melanoma. Cancer 1983;52:334–6.
Char DH . Metastatic choroidal melanoma. Am J Ophthalmol 1978;86:76–80.
Gragoudas ES, Seddon JM, Egan KM, Polivogianis L, Hsieh CC, Goiten M, et al. Prognostic factors for metastasis following proton beam irradiation of uveal melanomas. Ophthalmology 1986;93:675–80.
Birdsell JM, Gunther BK, Boyd TA, Grace M, Jerry LM . Ocular melanoma: a population-based study. Can J Ophthalmol 1980;15:9–12.
Einhorn LH, Burgess MA, Gottlieb JA . Metastatic patterns of choroidal melanoma. Cancer 1974;34:1001–4.
Jensen OA . Malignant melanomas of the uvea in Denmark 1943-1952. Acta Ophthalmol (Copenh) 1963;75(Suppl):146–7.
Zakka KA, Foos RY, Omphroy CA, Straatsma BR . Malignant melanoma: analysis of an autopsy population. Ophthalmology 1980;87:549–56.
Donoso LA, Nagy RM, Brockman RJ, Augsburger JJ, Shields JA, Berd D, et al. Metastatic uveal melanoma: hepatic cell-surface enzymes, isoenzymes and serum sialic acid levels in early metastatic disease. Arch Ophthalmol 1983;101:791–4.
Felberg NT, Shields JA, Maguire J, Piperata S, Amsel J . Gamma-glutamyl transpeptidase in the prognosis of patients with uveal malignant melanoma. Am J Ophthalmol 1983;95:467–73.
Donoso LA, Berd D, Augsburger JJ, Mastrangelo MJ, Shields JA . Metastatic uveal melanoma: pretherapy serum liver enzyme and liver scan abnormalities. Arch Ophthalmol 1985;103:796–8.
Zimmerman LE, McLean IW . Metastatic disease from untreated uveal melanomas. Am J Ophthalmol 1979;88:524–34.
Pach JM, Robertson DM . Metastasis from untreated unveal melanomas. Arch Ophthalmol 1986;104:1624–5.
Wagoner MD, Albert DM . The incidence of metastases from untreated ciliary body and choroidal melanoma. Arch Ophthalmol 1982;100:939–40.
Albert DM, Niffenegger AS, Willson JKV . Treatment of metastatic uveal melanoma: review and recommendations. Surv Ophthalmol 1992;36:429–38.
Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE . Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991;338:1227–9.
Tobal K, Sherman LS, Foss AJ, Lightman SL . Detection of melanocytes from uveal melanoma in peripheral blood using the polymerase chain reaction. Invest Ophthalmol Vis Sci 1993;34:2622–5.
Foss AJE, Guille MJ, Occleston NL, Hykin PG, Hungerford FL, Lightman SL . The detection of melanoma cells in peripheral blood by RT-PCR. Br J Cancer 1995;72:155–9.
Holmgren L, O'Reilly MS, Folkman J . Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 1995;1:149–53.
Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jockei K, Becher R . Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996;347:1222–5.
Foss AJE, Alexander RA, Jefferies LW, Hungerford JL, Harris AL, Lightman S . Microvessel count predicts survival in uveal melanoma. Cancer Res 1996;56:2900–3.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hicks, C., Foss, A. & Hungerford, J. Predictive power of screening tests for metastasis in uveal melanoma. Eye 12, 945–948 (1998). https://doi.org/10.1038/eye.1998.245
Issue Date:
DOI: https://doi.org/10.1038/eye.1998.245
Keywords
This article is cited by
-
Advances in the clinical management of uveal melanoma
Nature Reviews Clinical Oncology (2023)
-
GDF-15: a novel serum marker for metastases in uveal melanoma patients
Graefe's Archive for Clinical and Experimental Ophthalmology (2012)
-
Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma
European Journal of Nuclear Medicine and Molecular Imaging (2009)
-
“Melanoma inhibitory activity” (MIA): a promising serological tumour marker in metastatic uveal melanoma
Graefe's Archive for Clinical and Experimental Ophthalmology (2005)